TickerFacts.

Moderna, Inc. (MRNA): Share Repurchases

Annual figures by period end, from SEC filings.

$2.00M
Year ended 2025-12-31
-91.6%
3-year compound annual growth
$3.33B2019-12-31: $02020-12-31: $02021-12-31: $857.00M2022-12-31: $3.33B2023-12-31: $1.15B2024-12-31: $02025-12-31: $2.00M$2.00M
2019-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$2.00Mn/a2026-02-20, From 2025-01-01
2024-12-31$0-100.0%2026-02-20, From 2024-01-01
2023-12-31$1.15B-65.4%2026-02-20, From 2023-01-01
2022-12-31$3.33B+288.4%2025-02-21, From 2022-01-01
2021-12-31$857.00Mn/a2024-02-23, From 2021-01-01
2020-12-31$0n/a2023-02-24, From 2020-01-01
2019-12-31$0n/a2022-02-25, From 2019-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Moderna, Inc. (MRNA)2025-12-31$2.00Mn/a
Qiagen N.V. (QGEN)2025-12-31$280.09M-4.1%
Exelixis, Inc. (EXEL)2026-01-02$947.51M+45.3%
Halozyme Therapeutics, Inc. (HALO)2025-12-31$342.37M+36.9%
Neurocrine Biosciences Inc (NBIX)2025-12-31$167.70M-44.1%
Bio-Techne Corp (TECH)2026-06-30$41.67M-84.9%
Repligen Corp (RGEN)2025-12-31$0n/a
ADMA Biologics, Inc. (ADMA)2025-12-31$31.94Mn/a
Biogen Inc. (BIIB)2024-12-31$0n/a

Compare MRNA, QGEN, EXEL, HALO side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗